Collegium Pharmaceutical (COLL) Acquisitions (2018 - 2022)
Collegium Pharmaceutical (COLL) recorded quarterly Acquisitions of $572.1 million in Q1 2022, up 493062.93% quarter-over-quarter from $116000.0 in Q2 2018.
Collegium Pharmaceutical (COLL) Acquisitions (2018 - 2022) Analysis & Trends
Collegium Pharmaceutical's Acquisitions history runs 2 years deep, the most recent figure standing at $572.1 million for Q1 2022.
- In Q1 2022, Acquisitions changed N/A year-over-year to $572.1 million; the TTM figure through Dec 2022 stood at $572.1 million (changed N/A YoY), while the FY2024 annual figure was $267.5 million, changed N/A from the prior year.
- Acquisitions was $572.1 million for Q1 2022 at Collegium Pharmaceutical, up from $116000.0 in the prior quarter.
- In the past five years, Acquisitions ranged from a high of $572.1 million in Q1 2022 to a low of $116000.0 in Q2 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 2.09 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 137.87 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Collegium Pharmaceutical | 1.10 Bn | 813.71 Mn | 117.25 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 572.07 Mn |
| Jun 30, 2018 | 116,000.00 |
| Mar 31, 2018 | 18.76 Mn |